ポストバイオティクス市場：形態、タイプ、供給源、用途、流通チャネル別-2025-2030年の世界予測

ポストバイオティクス市場は、2023年に21億米ドルと評価され、2024年には22億5,000万米ドルに達すると予測され、CAGR 7.34％で成長し、2030年には34億6,000万米ドルに達すると予測されています。

ポストバイオティクス」とは、発酵中にプロバイオティクス微生物によって生産される生物活性化合物を指し、免疫反応の強化、炎症の軽減、消化器系の健康増進といった健康上のメリットを促進する上で極めて重要な役割を果たしています。機能性食品に対する認識と需要の高まりが、特に栄養補助食品、機能性食品、医薬品におけるポストバイオティクス市場を牽引しています。ライフスタイルの変化や慢性疾患の増加と相まって、腸の健康に対する消費者の関心が高まっていることから、ポストバイオティクスは生きたプロバイオティクスの貴重な代替品として、その安定性や生存性の問題を克服する必要性が強調されています。潜在的用途は栄養補助食品、栄養強化食品、スキンケア製品に及び、それぞれ飲食品産業、ヘルスケア、パーソナルケアなど異なる最終用途分野をターゲットとしています。市場成長の主な原動力は、そのメカニズムや効果を理解することを目的とした研究開発努力の高まりとともに、ポストバイオティクスの健康効果に関する知識の拡大です。新規の菌株、製剤、送達方法でイノベーションを起こすために研究開発に投資している企業は、特に個別化栄養とカスタムヘルスソリューションにおいて、大きなビジネスチャンスをつかむことができます。しかし、規制上の制約、消費者の認識不足、科学的実証の限界といった課題が、市場拡大の障害となっています。さらに、規制の枠組みにおけるポストバイオティクスの定義が複雑かつ断片的であることが、イノベーションを阻害する可能性があります。規制状況には、健康強調表示を実証するための確かな臨床研究に注力すること、消費者の認識を高めるための教育キャンペーンに取り組むこと、規制の状況を効率的に把握することなどが含まれます。技術革新が必要な分野としては、ポストバイオティクスの安定性、有効性、デリバリーの強化があり、先進的な発酵技術や生物工学を利用することも考えられます。急速な科学の進歩と消費者の嗜好の変化を特徴とする市場のダイナミックな性質は、競争上の優位性と持続可能な成長を確保するための機敏な研究戦略と提携を必要とします。

市場力学：急速に進化するポストバイオティクス市場の主要市場インサイトを公開

ポストバイオティクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 医療専門家や消費者の間でのポストバイオティクスの健康効果に対する認識
  • 世界のナチュラルでクリーンなサプリメント製品への嗜好
  • コンビニエンス食品や飲食品におけるポストバイオティクスの活用
• 市場抑制要因
  • ポストバイオティクス製品のリコール
• 市場機会
  • ポストバイオティクス製品の処方および製造技術の進歩
  • 栄養学における非乳製品ポストバイオティクスの人気上昇
• 市場の課題
  • ポストバイオティクスの標準化と品質維持の複雑さ

ポーターのファイブフォース：ポストバイオティクス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、ポストバイオティクス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ポストバイオティクス市場における外部からの影響の把握

外部マクロ環境要因は、ポストバイオティクス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ポストバイオティクス市場における競合情勢の把握

ポストバイオティクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスポストバイオティクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ポストバイオティクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ポストバイオティクス市場における成功への道筋を描く

ポストバイオティクス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ヘルスケア従事者と消費者の間でのポストバイオティクスの健康上の利点の認識
    • 世界中で自然でクリーンなラベルのサプリメント製品が好まれる
    • コンビニエンス飲食品におけるポストバイオティクスの活用
  • 抑制要因
    • ポストバイオティクス製品の有害リコール
  • 機会
    • ポストバイオティクス製品の処方および製造技術の進歩
    • 栄養学における非乳製品ポストバイオティクスの人気の高まり
  • 課題
    • ポストバイオティクスの標準化と品質維持の複雑さ
• 市場セグメンテーション分析
  • 形態：飲食品業界では導入の容易さから液体ポストバイオティクスの使用が増加している
  • 応用：健康と生産性の向上における業界全体のポストバイオティクスの利点についての認識の高まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ポストバイオティクス市場：形態別

• 液体
• 粉

第7章 ポストバイオティクス市場：タイプ別

• 細菌溶解物
• 細胞壁の断片
• 無細胞上清
• 酵素
• 細胞外多糖類
• リポ多糖類
• 短鎖脂肪酸
• ビタミンとアミノ酸

第8章 ポストバイオティクス市場：ソース別

• 細菌
• 酵母

第9章 ポストバイオティクス市場：用途別

• 動物飼料
• 飲食品
• パーソナルケア・化粧品
• 医薬品

第10章 ポストバイオティクス市場：流通チャネル別

• オフライン
• オンライン

第11章 南北アメリカのポストバイオティクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のポストバイオティクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのポストバイオティクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ケリーグループは、人間とペットの消化器系と皮膚の健康を高める新しい米由来のポストバイオティクス、プレニバイオティックを発売しました。
  • テトラパックとABバイオテックは戦略的提携を通じてポストバイオティクスを配合した食品と飲料の新たなイノベーションを発表
  • DSM-FirmenichがAdare Biomeを2億7,500万ユーロで買収し、ポストバイオティクスの能力を強化し、人間と動物の健康分野での事業拡大を図る
• 戦略分析と提言

企業一覧

• Archer-Daniels-Midland Company
• Beekeeper's Naturals, Inc.
• Bioflag Group
• Cargill Incorporated
• Dr. Emil Nutrition, LLC
• DSM-Firmenich AG
• Essential Formulas Incorporated
• GeneFerm Biotechnology Co., Ltd.
• Gundry MD
• GutArmor by Get Wellness, LLC
• Healist Naturals, LLC
• Ildong Pharmaceutical Co., Ltd.
• Kerry Group PLC
• Kirin Holdings Company, Limited
• Lactobio A/S
• Maypro Group
• MCLS Europe B.V.
• MRM Nutrition
• Otemchi Biotechnologies Pte. Ltd.
• Phileo by Lesaffre
• Postbiotics Inc.
• Probiotics Australia Pty., Ltd.
• Probioway Co., Ltd.
• Sabinsa Corporation
• Silab SA
• Symbiotec Pharmalab Pvt. Ltd.
• T.H.T. sa
• woresan GmbH
• POSTBIOTICA S.R.L.

LIST OF FIGURES

• FIGURE 1. POSTBIOTICS MARKET RESEARCH PROCESS
• FIGURE 2. POSTBIOTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL POSTBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL POSTBIOTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL POSTBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL POSTBIOTICS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL POSTBIOTICS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL POSTBIOTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL POSTBIOTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL POSTBIOTICS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL POSTBIOTICS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS POSTBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS POSTBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES POSTBIOTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES POSTBIOTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. POSTBIOTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. POSTBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. POSTBIOTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL POSTBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL POSTBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. POSTBIOTICS MARKET DYNAMICS
• TABLE 7. GLOBAL POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL POSTBIOTICS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL POSTBIOTICS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL POSTBIOTICS MARKET SIZE, BY BACTERIAL LYSATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL POSTBIOTICS MARKET SIZE, BY CELL WALL FRAGMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL POSTBIOTICS MARKET SIZE, BY CELL-FREE SUPERNATANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL POSTBIOTICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL POSTBIOTICS MARKET SIZE, BY EXOPOLYSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL POSTBIOTICS MARKET SIZE, BY LIPOPOLYSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL POSTBIOTICS MARKET SIZE, BY SHORT-CHAIN FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL POSTBIOTICS MARKET SIZE, BY VITAMINS & AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL POSTBIOTICS MARKET SIZE, BY BACTERIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL POSTBIOTICS MARKET SIZE, BY YEAST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL POSTBIOTICS MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL POSTBIOTICS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL POSTBIOTICS MARKET SIZE, BY PERSONAL CARE & COSMETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL POSTBIOTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL POSTBIOTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. CANADA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 47. CANADA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CANADA POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 49. CANADA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. CANADA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES POSTBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. CHINA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 74. CHINA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. CHINA POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 76. CHINA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. CHINA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. INDIA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 79. INDIA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. INDIA POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 81. INDIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. INDIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 164. ITALY POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 165. ITALY POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. ITALY POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 167. ITALY POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. ITALY POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 184. POLAND POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 185. POLAND POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. POLAND POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 187. POLAND POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. POLAND POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. QATAR POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 190. QATAR POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. QATAR POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 192. QATAR POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. QATAR POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM POSTBIOTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 239. POSTBIOTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 240. POSTBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Postbiotics Market was valued at USD 2.10 billion in 2023, expected to reach USD 2.25 billion in 2024, and is projected to grow at a CAGR of 7.34%, to USD 3.46 billion by 2030.

The term "postbiotics" refers to bioactive compounds produced by probiotic microorganisms during fermentation, playing a pivotal role in promoting health benefits like enhanced immune response, reduced inflammation, and improved digestive health. The growing awareness and demand for functional foods drive the postbiotics market, especially in dietary supplements, functional foods, and pharmaceuticals. Increasing consumer interest in gut health, combined with lifestyle changes and the rise of chronic diseases, underscores the necessity for postbiotics as they present a valuable alternative to live probiotics, overcoming their stability and viability issues. Potential applications span nutraceuticals, fortified foods, and skincare products, each targeting different end-use sectors like the food and beverage industry, healthcare, and personal care. Market growth is chiefly driven by the expanding knowledge of postbiotics' health benefits, alongside heightened research and development efforts aimed at understanding their mechanisms and effects. Companies investing in R&D to innovate with novel strains, formulations, and delivery methods stand to seize substantial opportunities, especially in personalized nutrition and custom health solutions. However, challenges such as regulatory constraints, insufficient awareness among consumers, and limited scientific substantiation pose hurdles to market expansion. Additionally, the complex and fragmented nature of the postbiotic definitions within regulatory frameworks can stifle innovation. Recommendations include focusing on robust clinical research to substantiate health claims, engaging in educational campaigns to raise consumer awareness, and navigating regulatory landscapes efficiently. Areas ripe for innovation include enhancing postbiotic stability, efficacy, and delivery, potentially by exploiting advanced fermentation technologies or bioengineering. The market's dynamic nature, characterized by rapid scientific advancements and evolving consumer preferences, necessitates agile research strategies and partnership alliances to ensure competitive advantage and sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Postbiotics Market

The Postbiotics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Awareness of health benefits of postbiotics among healthcare professionals and consumers
  • Preference for natural and clean-label supplement products worldwide
  • Utilization of postbiotics in convenience food and beverages
• Market Restraints
  • Adverse recalls of postbiotic products
• Market Opportunities
  • Advancements in formulation and production technologies of postbiotic products
  • Rising popularity of non-dairy postbiotics in nutrition
• Market Challenges
  • Complexity in standardization and quality maintenance of postbiotics

Porter's Five Forces: A Strategic Tool for Navigating the Postbiotics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Postbiotics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Postbiotics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Postbiotics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Postbiotics Market

A detailed market share analysis in the Postbiotics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Postbiotics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Postbiotics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Postbiotics Market

A strategic analysis of the Postbiotics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Postbiotics Market, highlighting leading vendors and their innovative profiles. These include Archer-Daniels-Midland Company, Beekeeper's Naturals, Inc., Bioflag Group, Cargill Incorporated, Dr. Emil Nutrition, LLC, DSM-Firmenich AG, Essential Formulas Incorporated, GeneFerm Biotechnology Co., Ltd., Gundry MD, GutArmor by Get Wellness, LLC, Healist Naturals, LLC, Ildong Pharmaceutical Co., Ltd., Kerry Group PLC, Kirin Holdings Company, Limited, Lactobio A/S, Maypro Group, MCLS Europe B.V., MRM Nutrition, Otemchi Biotechnologies Pte. Ltd., Phileo by Lesaffre, Postbiotics Inc., Probiotics Australia Pty., Ltd., Probioway Co., Ltd., Sabinsa Corporation, Silab SA, Symbiotec Pharmalab Pvt. Ltd., T.H.T. sa, woresan GmbH, and POSTBIOTICA S.R.L..

Market Segmentation & Coverage

This research report categorizes the Postbiotics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Form, market is studied across Liquid and Powder.
• Based on Type, market is studied across Bacterial Lysates, Cell Wall Fragments, Cell-Free Supernatants, Enzymes, Exopolysaccharides, Lipopolysaccharides, Short-Chain Fatty Acids, and Vitamins & Amino Acids.
• Based on Source, market is studied across Bacteria and Yeast.
• Based on Application, market is studied across Animal Feed, Food & Beverage, Personal Care & Cosmetics, and Pharmaceuticals.
• Based on Distribution Channel, market is studied across Offline and Online.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Awareness of health benefits of postbiotics among healthcare professionals and consumers
    • 5.1.1.2. Preference for natural and clean-label supplement products worldwide
    • 5.1.1.3. Utilization of postbiotics in convenience food and beverages
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse recalls of postbiotic products
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in formulation and production technologies of postbiotic products
    • 5.1.3.2. Rising popularity of non-dairy postbiotics in nutrition
  • 5.1.4. Challenges
    • 5.1.4.1. Complexity in standardization and quality maintenance of postbiotics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Forms: Rising use of liquid postbiotics in the food & beverage sector owing to the ease of incorporation
  • 5.2.2. Application: Growing awareness about the benefits of postbiotics across industries in enhancing health and productivity
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Postbiotics Market, by Form

• 6.1. Introduction
• 6.2. Liquid
• 6.3. Powder

7. Postbiotics Market, by Type

• 7.1. Introduction
• 7.2. Bacterial Lysates
• 7.3. Cell Wall Fragments
• 7.4. Cell-Free Supernatants
• 7.5. Enzymes
• 7.6. Exopolysaccharides
• 7.7. Lipopolysaccharides
• 7.8. Short-Chain Fatty Acids
• 7.9. Vitamins & Amino Acids

8. Postbiotics Market, by Source

• 8.1. Introduction
• 8.2. Bacteria
• 8.3. Yeast

9. Postbiotics Market, by Application

• 9.1. Introduction
• 9.2. Animal Feed
• 9.3. Food & Beverage
• 9.4. Personal Care & Cosmetics
• 9.5. Pharmaceuticals

10. Postbiotics Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Offline
• 10.3. Online

11. Americas Postbiotics Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Postbiotics Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Postbiotics Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Kerry Group launches Plenibiotic, a novel rice-derived postbiotic to enhance digestive and skin health for humans and pets
  • 14.3.2. Tetra Pak and AB Biotek present new innovations for postbiotic-infused foods and beverages through strategic partnership
  • 14.3.3. DSM-Firmenich acquires Adare Biome for Euro 275 million to boost postbiotics capabilities and expand in human and animal health sectors
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Archer-Daniels-Midland Company
• 2. Beekeeper's Naturals, Inc.
• 3. Bioflag Group
• 4. Cargill Incorporated
• 5. Dr. Emil Nutrition, LLC
• 6. DSM-Firmenich AG
• 7. Essential Formulas Incorporated
• 8. GeneFerm Biotechnology Co., Ltd.
• 9. Gundry MD
• 10. GutArmor by Get Wellness, LLC
• 11. Healist Naturals, LLC
• 12. Ildong Pharmaceutical Co., Ltd.
• 13. Kerry Group PLC
• 14. Kirin Holdings Company, Limited
• 15. Lactobio A/S
• 16. Maypro Group
• 17. MCLS Europe B.V.
• 18. MRM Nutrition
• 19. Otemchi Biotechnologies Pte. Ltd.
• 20. Phileo by Lesaffre
• 21. Postbiotics Inc.
• 22. Probiotics Australia Pty., Ltd.
• 23. Probioway Co., Ltd.
• 24. Sabinsa Corporation
• 25. Silab SA
• 26. Symbiotec Pharmalab Pvt. Ltd.
• 27. T.H.T. sa
• 28. woresan GmbH
• 29. POSTBIOTICA S.R.L.